-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM ANNOUNCES POSITIVE INITIAL PHASE 1B DATA FOR BREZOSIRAN (ALN-HTT02) DEMONSTRATING DEEP AND DURABLE HUNTINGTIN LOWERING IN HUNTINGTON’S DISEASE

Reuters·10/23/2026 07:45:00

Please log in to view news